BNTX logo

BioNTech SE (BNTX) Cash from investing

annual CFI:

-$2.25B+$5.28B(+70.08%)
December 31, 2024

Summary

  • As of today (May 29, 2025), BNTX annual cash flow from investing activities is -$2.25 billion, with the most recent change of +$5.28 billion (+70.08%) on December 31, 2024.
  • During the last 3 years, BNTX annual CFI has fallen by -$1.58 billion (-236.31%).
  • BNTX annual CFI is now -5950.91% below its all-time high of -$37.23 million, reached on December 31, 2022.

Performance

BNTX Cash from investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

quarterly CFI:

$1.31B+$608.33M(+86.46%)
March 1, 2025

Summary

  • As of today (May 29, 2025), BNTX quarterly cash flow from investing activities is $1.31 billion, with the most recent change of +$608.33 million (+86.46%) on March 1, 2025.
  • Over the past year, BNTX quarterly CFI has increased by +$3.81 billion (+152.41%).
  • BNTX quarterly CFI is now at all-time high.

Performance

BNTX quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

TTM CFI:

$1.56B+$3.81B(+169.36%)
March 1, 2025

Summary

  • As of today (May 29, 2025), BNTX TTM cash flow from investing activities is $1.56 billion, with the most recent change of +$3.81 billion (+169.36%) on March 1, 2025.
  • Over the past year, BNTX TTM CFI has increased by +$10.80 billion (+116.90%).
  • BNTX TTM CFI is now at all-time high.

Performance

BNTX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBNTXcash flow metrics

Cash from investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BNTX Cash from investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+70.1%+152.4%+116.9%
3 y3 years-236.3%+306.8%+598.8%
5 y5 years-2506.4%+8078.7%+2496.6%

BNTX Cash from investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-5950.9%+70.1%at high+145.4%at high+116.9%
5 y5-year-5950.9%+70.1%at high+145.4%at high+116.9%
alltimeall time-5950.9%+70.1%at high+145.4%at high+116.9%

BNTX Cash from investing History

DateAnnualQuarterlyTTM
Mar 2025
-
$1.31B(+86.5%)
$1.56B(-169.4%)
Dec 2024
-$2.25B(-70.1%)
$703.59M(-427.3%)
-$2.25B(-61.5%)
Sep 2024
-
-$214.99M(-9.7%)
-$5.85B(-16.1%)
Jun 2024
-
-$238.16M(-90.5%)
-$6.97B(-24.6%)
Mar 2024
-
-$2.50B(-13.4%)
-$9.24B(+22.8%)
Dec 2023
-$7.53B(>+9900.0%)
-$2.89B(+116.3%)
-$7.53B(+56.8%)
Sep 2023
-
-$1.34B(-46.8%)
-$4.80B(+34.8%)
Jun 2023
-
-$2.51B(+217.9%)
-$3.56B(+209.8%)
Mar 2023
-
-$789.85M(+382.0%)
-$1.15B(+2988.0%)
Dec 2022
-$37.23M(-94.4%)
-$163.85M(+70.7%)
-$37.23M(-672.3%)
Sep 2022
-
-$95.99M(-3.9%)
$6.51M(-101.7%)
Jun 2022
-
-$99.88M(-131.0%)
-$377.16M(+20.4%)
Mar 2022
-
$322.50M(-368.5%)
-$313.20M(-53.2%)
DateAnnualQuarterlyTTM
Dec 2021
-$669.80M(+305.0%)
-$120.12M(-75.0%)
-$669.80M(+1.1%)
Sep 2021
-
-$479.66M(+1235.4%)
-$662.42M(+218.2%)
Jun 2021
-
-$35.92M(+5.3%)
-$208.18M(+13.7%)
Mar 2021
-
-$34.10M(-69.8%)
-$183.02M(+10.7%)
Dec 2020
-$165.37M(+91.3%)
-$112.74M(+343.5%)
-$165.37M(+156.4%)
Sep 2020
-
-$25.42M(+136.3%)
-$64.50M(+3.7%)
Jun 2020
-
-$10.76M(-34.6%)
-$62.21M(-4.6%)
Mar 2020
-
-$16.44M(+38.5%)
-$65.19M(-24.6%)
Dec 2019
-$86.43M(+10.1%)
-$11.88M(-48.7%)
-$86.43M(+15.9%)
Sep 2019
-
-$23.14M(+68.4%)
-$74.55M(+45.0%)
Jun 2019
-
-$13.74M(-63.5%)
-$51.41M(+36.5%)
Mar 2019
-
-$37.68M
-$37.68M
Dec 2018
-$78.47M(+31.9%)
-
-
Dec 2017
-$59.51M
-
-

FAQ

  • What is BioNTech SE annual cash flow from investing activities?
  • What is the all time high annual CFI for BioNTech SE?
  • What is BioNTech SE annual CFI year-on-year change?
  • What is BioNTech SE quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for BioNTech SE?
  • What is BioNTech SE quarterly CFI year-on-year change?
  • What is BioNTech SE TTM cash flow from investing activities?
  • What is the all time high TTM CFI for BioNTech SE?
  • What is BioNTech SE TTM CFI year-on-year change?

What is BioNTech SE annual cash flow from investing activities?

The current annual CFI of BNTX is -$2.25B

What is the all time high annual CFI for BioNTech SE?

BioNTech SE all-time high annual cash flow from investing activities is -$37.23M

What is BioNTech SE annual CFI year-on-year change?

Over the past year, BNTX annual cash flow from investing activities has changed by +$5.28B (+70.08%)

What is BioNTech SE quarterly cash flow from investing activities?

The current quarterly CFI of BNTX is $1.31B

What is the all time high quarterly CFI for BioNTech SE?

BioNTech SE all-time high quarterly cash flow from investing activities is $1.31B

What is BioNTech SE quarterly CFI year-on-year change?

Over the past year, BNTX quarterly cash flow from investing activities has changed by +$3.81B (+152.41%)

What is BioNTech SE TTM cash flow from investing activities?

The current TTM CFI of BNTX is $1.56B

What is the all time high TTM CFI for BioNTech SE?

BioNTech SE all-time high TTM cash flow from investing activities is $1.56B

What is BioNTech SE TTM CFI year-on-year change?

Over the past year, BNTX TTM cash flow from investing activities has changed by +$10.80B (+116.90%)
On this page